These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9786567)

  • 1. Report of tissue plasminogen activator (tPA) injection in a very low dose for the treatment of posttrabeculectomy fibrin.
    Burnstein Y; Higginbotham EJ
    J Glaucoma; 1998 Oct; 7(5):361. PubMed ID: 9786567
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
    Erol N; Ozer A; Topbas S; Yildirim N; Yurdakul S
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):451-6. PubMed ID: 14620747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of subconjunctivally administered tissue plasminogen activator after trabeculectomy.
    Piltz JR; Starita RJ
    Ophthalmic Surg; 1994 Jan; 25(1):51-3. PubMed ID: 8152734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracameral tissue plasminogen activator to treat blocked glaucoma implants.
    Richards DW
    Ophthalmic Surg; 1993 Dec; 24(12):854-5. PubMed ID: 8115105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of tissue plasminogen activator in the post-operative treatment of fibrinoid uveitis].
    Chiseliţă D; Antohi I; Cionca D; Medvichi R; Cimpoeşu D
    Oftalmologia; 2006; 50(2):68-72. PubMed ID: 16927762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis of postcataract fibrin membranes in children.
    Leung AT; Lam DS; Rao SK
    J Cataract Refract Surg; 2000 Jan; 26(1):4; author reply 5. PubMed ID: 10646130
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose tissue plasminogen activator in the management of anterior chamber fibrin formation.
    Georgiadis N; Boboridis K; Halvatzis N; Ziakas N; Moschou V
    J Cataract Refract Surg; 2003 Apr; 29(4):729-32. PubMed ID: 12686240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue plasminogen activator for treatment of fibrin in endophthalmitis.
    Damji KF; O'Connor MD; Hill V
    Can J Ophthalmol; 2001 Aug; 36(5):269-71. PubMed ID: 11548143
    [No Abstract]   [Full Text] [Related]  

  • 9. Intracameral tissue plasminogen activator after glaucoma surgery. Indications, effectiveness, and complications.
    Lundy DC; Sidoti P; Winarko T; Minckler D; Heuer DK
    Ophthalmology; 1996 Feb; 103(2):274-82. PubMed ID: 8594514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator in the management of anterior chamber fibrin formation.
    Erol N
    J Cataract Refract Surg; 2004 Nov; 30(11):2254-5; author reply 2255. PubMed ID: 15519061
    [No Abstract]   [Full Text] [Related]  

  • 11. Intracameral tissue plasminogen activator: management of a fibrin clot occluding a Molteno tube.
    Pastor SA; Schumann SP; Starita RJ; Fellman RL
    Ophthalmic Surg; 1993 Dec; 24(12):853-4. PubMed ID: 8115104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.
    Koerner F; Boehnke M
    Ger J Ophthalmol; 1992; 1(5):354-60. PubMed ID: 1477641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolysis of postcataract fibrin membranes in children.
    Mehta JS; Adams GG
    J Cataract Refract Surg; 2000 Jan; 26(1):4-5. PubMed ID: 10646131
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical tissue plasminogen activator appears ineffective for the clearance of intraocular fibrin.
    Zwaan J; Latimer WB
    Ophthalmic Surg Lasers; 1998 Jun; 29(6):476-83. PubMed ID: 9640569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery.
    Wedrich A; Menapace R; Ries E; Polzer I
    J Cataract Refract Surg; 1997; 23(6):873-7. PubMed ID: 9292671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of tissue plasminogen activator to revive blebs following intraocular surgery.
    Smith MF; Doyle JW
    Arch Ophthalmol; 2001 Jun; 119(6):809-12. PubMed ID: 11405830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.
    Schmitz K; Greite JH; Bartenschlager EM
    Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic application of tissue plasminogen activator for fibrin reaction after cataract surgery.
    Ozveren F; Eltutar K
    J Cataract Refract Surg; 2004 Aug; 30(8):1727-31. PubMed ID: 15313298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
    Hassan AS; Johnson MW; Schneiderman TE; Regillo CD; Tornambe PE; Poliner LS; Blodi BA; Elner SG
    Ophthalmology; 1999 Oct; 106(10):1900-6; discussion 1906-7. PubMed ID: 10519583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with tissue plasminogen activator (tPA) in risk patients with fibrin reactions after cataract operations].
    Heiligenhaus A; Schilling H; Schilling M; Mellin KB
    Ophthalmologe; 1996 Feb; 93(1):49-53. PubMed ID: 8867161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.